Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

BACKGROUND: To investigate whether copy number gain of MET or hepatocyte growth factor (HGF) affect trastuzumab sensitivity in HER2-positive metastatic breast cancer (MBC). METHODS: We analysed 130 HER2-positive MBC treated with trastuzumab-based therapy. MET and HGF gene copy numbers (GCN) were ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Minuti, G, Cappuzzo, F, Duchnowska, R, Jassem, J, Fabi, A, O’Brien, T, Mendoza, A D, Landi, L, Biernat, W, Czartoryska-Arłukowicz, B, Jankowski, T, Zuziak, D, Zok, J, Szostakiewicz, B, Foszczyńska-Kłoda, M, Tempińska-Szałach, A, Rossi, E, Varella-Garcia, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425981/
https://www.ncbi.nlm.nih.gov/pubmed/22850551
http://dx.doi.org/10.1038/bjc.2012.335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425981/
https://www.ncbi.nlm.nih.gov/pubmed/22850551
http://dx.doi.org/10.1038/bjc.2012.335

Ejemplares similares